Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer
Open Access
- 2 May 2021
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 10 (10) , 3332-3345
Abstract
Mining databases and data obtained from assays on human specimens had shown that Fzd7 is closely associated with Wnt7b, that Fzd7/Wnt7b expression is upregulated in pancreatic cancer tissues compared with normal tissues, and its expression is negatively correlated with survival. Fzd7/Wnt7b knockdown in Capan‐2 and Panc‐1 cells reduced the proliferative capacity of pancreatic cancer stem cells (PCSCs), reduced drug resistance, decreased the percentage of CD24+CD44+ subset of cells and the levels of ABCG2, inhibited cell‐sphere formation, and reduced gemcitabine (GEM) resistance. In contrast, Fzd7/Wnt7b overexpression increased the percentage of the CD24+CD44+ subset of cells, and increased the levels of ABCG2 detected in cell spheroids. The gem‐resistant cells exhibited higher levels of Fzd7/Wnt7b expression, an increased percentage of CD24+CD44+ cells, and higher levels of ABCG2 compared with the parental cells. Taken together, Fzd7/Wnt7b knockdown can reduce PDAC cell stemness and chemoresistance by reducing the percentage of CSCs. Mechanistically, Fzd7 binds with Wnt7b and modulates the levels of β‐catenin, and they may exert their role via modulation of the canonical Wnt pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81572360)
This publication has 44 references indexed in Scilit:
- WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinomaOncogene, 2013
- Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemiaBMC Cancer, 2012
- Identification of Glycoprotein Markers for Pancreatic Cancer CD24+CD44+ Stem-like Cells Using Nano-LC–MS/MS and Tissue MicroarrayJournal of Proteome Research, 2012
- Genotypic and Phenotypic Characterization of Side Population of Gastric Cancer Cell LinesThe American Journal of Pathology, 2011
- Cancer Stem-Like Cells Enriched in Panc-1 Spheres Possess Increased Migration Ability and Resistance to GemcitabineInternational Journal of Molecular Sciences, 2011
- Pancreatic cancer spheres are more than just aggregates of stem marker-positive cellsBioscience Reports, 2010
- Pancreatic CancerNew England Journal of Medicine, 2010
- CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer, 2009
- Pancreatic cancer stem cells: Fact or fiction?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008